Molecular biology of human papillomavirus infection and cervical cancer
The DOI matches its Crossref record; 172 of the 179 references it cites were found in a registry or an index.
Abstract
HPVs (human papillomaviruses) infect epithelial cells and cause a variety of lesions ranging from common warts/verrucas to cervical neoplasia and cancer. Over 100 different HPV types have been identified so far, with a subset of these being classified as high risk. High-risk HPV DNA is found in almost all cervical cancers (>99.7%), with HPV16 being the most prevalent type in both low-grade disease and cervical neoplasia. Productive infection by high-risk HPV types is manifest as cervical flat warts or condyloma that shed infectious virions from their surface. Viral genomes are maintained as episomes in the basal layer, with viral gene expression being tightly controlled as the infected cells move towards the epithelial surface. The pattern of viral gene expression in low-grade cervical lesions resembles that seen in productive warts caused by other HPV types. High-grade neoplasia represents an abortive infection in which viral gene expression becomes deregulated, and the normal life cycle of the virus cannot be completed. Most cervical cancers arise within the cervical transformation zone at the squamous/columnar junction, and it has been suggested that this is a site where productive infection may be inefficiently supported. The high-risk E6 and E7 proteins drive cell proliferation through their association with PDZ domain proteins and Rb (retinoblastoma), and contribute to neoplastic progression, whereas E6-mediated p53 degradation prevents the normal repair of chance mutations in the cellular genome. Cancers usually arise in individuals who fail to resolve their infection and who retain oncogene expression for years or decades. In most individuals, immune regression eventually leads to clearance of the virus, or to its maintenance in a latent or asymptomatic state in the basal cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“human papillomavirus (HPV) is thought to initiate cervical carcinoma and squamous cell carcinoma of the head and neck in part by inactivating RB through expression of the E7 oncoprotein21,22”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [21]
In the citing paper
“in HPV-induced cervical cancers, the virus initiates cancer in dividing cells in the basal layer of the epithelium, preventing their normal cell cycle exit and maturation21.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [21]
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Classification of papillomaviruses
de Villiers, E.-M., Fauquet, C., Broker, T. R., Bernard, H.-U., & zur Hausen, H. (2004) · Virology · doi:10.1016/j.virol.2004.03.033 · Cited by 3,193
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
Clifford, G. M., Smith, J. S., Plummer, M., Muñoz, N., & Franceschi, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600688 · Cited by 1,561
Barrier Function of the Skin: “La Raison d'Être” of the Epidermis
Madison, K. C. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12359.x · Cited by 1,188
Muñoz, N., Bosch, F. X., Castellsagué, X., Díaz, M., de Sanjose, S., Hammouda, D., Shah, K. V., & Meijer, C. J. L. M. (2004) · International Journal of Cancer · doi:10.1002/ijc.20244 · Cited by 1,104
Clifford, G., Gallus, S., Herrero, R., Muñoz, N., Snijders, P., Vaccarella, S., Anh, P., Ferreccio, C., Hieu, N., Matos, E., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67069-9 · Cited by 1,093
Münger, K., Phelps, W. C., Bubb, V, Howley, P. M., & Schlegel, R. (1989) · Journal of Virology · doi:10.1128/jvi.63.10.4417-4421.1989 · Cited by 1,030
Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer
Storey, A., Thomas, M., Kalita, A., Harwood, C., Gardiol, D., Mantovani, F., Breuer, J., Leigh, I. M., Matlashewski, G., & Banks, L. (1998) · Nature · doi:10.1038/30400 · Cited by 974
Koutsky, L. A., Holmes, K. K., Critchlow, C. W., Stevens, C. E., Paavonen, J., Beckmann, A. M., DeRouen, T. A., Galloway, D. A., Vernon, D., & Kiviat, N. B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210293271804 · Cited by 943
Research works printed but not linked: 2
- Villiers de, 2001, Taxonomic classification of papillomaviruses, Papillomavirus Rep., 12, 57
- Sorathia, 2004, The E4 protein of HPV16 Interacts with E2 and regulates the trans-activation and replication functions of E2, 318
Cited by
Items 201–300 of 1,000
Human papillomavirus in oral atrophic lichen planus lesions
Mattila, R., Rautava, J., & Syrjänen, S. (2012) · Oral Oncology · doi:10.1016/j.oraloncology.2012.04.009 · Cited by 50
“In HPV-infected keratinocytes, however, the restraint on cell-cycle progression is lost and normal terminal differentiation does not occur.(27) Because only a small number of HPV-infected cells expand it, it is also expected that static cytometry is more sensitive to identify HPV infection than the proliferation marke…”
Sheu, B., Chang, W., Lin, H., Chow, S., & Huang, S. (2007) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2007.00492.x · Cited by 51
“7%) cervical cancer tissues.(7,8) Studies”
BackgroundTong, Y.-Q., Liu, B., Zheng, H.-Y., Gu, J. H., Liu, H., Li, F., Tan, B., Hartman, M., Song, C., & Li, Y. (2015) · Oncotarget · doi:10.18632/oncotarget.4622 · Cited by 50
“The relation of miR-215 overexpression with the progression of cancer indicates its important role as an oncogene in cancer progression [22].”
BackgroundHakim, R. U., Amin, T., & Islam, S. M. B. U. (2025) · Cancer Control · doi:10.1177/10732748251336415 · Cited by 58
“There are 14 types of high-risk HPV, namely HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, and 73.”
Chung, T. K. H., Hummelen, P. V., Chan, P. K. S., Cheung, T. H., Yim, S. F., Yu, M. Y., Ducar, M. D., Thorner, A. R., MacConaill, L. E., Doran, G., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29456 · Cited by 51
“One well-documented oncogenic pathway mediated by integration of HPV into human genome is the disruption of viral gene E2, which leads to a loss of control over the expression of the viral oncogenes E6 and E7, resulting in interruption of the normal tumor suppressing role of p53 and pRb.(27) In our study, we detected…”
BackgroundLlamas-Martínez, S., Gómez, G. E., Campo, J., Cancela-Rodríguez, P., Martínez, A. B., López, L. A. M., García‐Nuñez, J. A., & Lapiedra, R. C. (2008) · PubMed · Cited by 49
The impact of HPV infection on human glycogen and lipid metabolism – a review
Sitarz, K., Czamara, K., Szostek, S., & Kaczor, A. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188646 · Cited by 53
Ojha, P. S., Maste, M. M., Tubachi, S. S., & Patil, V. S. (2022) · VirusDisease · doi:10.1007/s13337-022-00768-w · Cited by 56
“Exposure of the immature basal layer cells to HPV can occur due to minute abrasions that occur during sexual intercourse [22, 23].”
BackgroundReuschenbach, M., Pauligk, C., Karbach, J., Rafiyan, M., Kloor, M., Prigge, E., Sauer, M., Al‐Batran, S., Kaufmann, A. M., Schneider, A., et al. (2016) · Cancer · doi:10.1002/cncr.29925 · Cited by 53
“These numbers can be considered to be very promising and entirely comparable to what has been observed before with viral peptide antigens HPV E6 and E7.”
BackgroundBmi-1 cooperates with human papillomavirus type 16 E6 to immortalize normal human oral keratinocytes
Kim, R. H., Kang, M., Shin, K.-H., Oo, Z. M., Han, T., Baluda, M. A., & Park, N. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.10.025 · Cited by 54
“tion of cellular proteins such as p53 and PDZ-containing proteins [35].”
BackgroundYim, E.-K., & Park, J. S. (2006) · Biomarker Insights · doi:10.1177/117727190600100015 · Cited by 48
“Most cervical cancers arise within the cervical transformation zone at the squamous/columnar junction, and it has been suggested that this is a site where productive infection may be ineffi ciently supported (Doorbar, 2006).”
BackgroundPredicting PDZ domain mediated protein interactions from structure
Hui, S., Xing, X., & Bader, G. D. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-27 · Cited by 51
“; licensee BioMed Central Ltd Commons Attribution License (http://creativec reproduction in any medium, provided the or human genome) and association with diseases such as cystic fibrosis and schizophrenia, and pathogens, such as human papillomavirus [2-4].”
BackgroundHPV-related oropharyngeal cancers: From pathogenesis to new therapeutic approaches
Tornesello, M. L., Perri, F., Buonaguro, L., Ionna, F., Buonaguro, L., & Caponigro, F. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.06.003 · Cited by 47
“In high grade intraepithelial lesions (HSIL) and invasive cancers the early genes E6 and E7 are expressed in all epithelial layers and are responsible for deregulation of several cellular pathways relevant for cell transformation [37,40].”
BackgroundAkhras, M. S., Unemo, M., Thiyagarajan, S., Nyrén, P., Davis, R. W., Fire, A. Z., & Pourmand, N. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000915 · Cited by 48
“CSP-CIPer exclusively detected genotypes HPV-27 and -29, while GP5+/6+ PCR exclusively detected genotypes HPV28, -53, -71, -72, and -82 (only HPV-53 is categorized as a high-risk genotype [20]).”
BackgroundOstrowska, K. M., Garcia, A., Meade, A. D., Malkin, A., Okewumi, I., O’Leary, J. J., Martin, C. M., Byrne, H. J., & Lyng, F. M. (2011) · The Analyst · doi:10.1039/c0an00910e · Cited by 48
Verdoodt, F., Szarewski, A., Halfon, P., Cuschieri, K. S., & Arbyn, M. (2013) · Cancer Cytopathology · doi:10.1002/cncy.21325 · Cited by 53
“It is now accepted that the overexpression of E6=E7 is requisite for HPV-driven oncogenesis, and the presence of E6=E7 in surface epithelial cells, which are harvested during smear-taking, may be indicative of a deregulated expression.(21,22) In terms of application, this theory reconciles with evidence demonstrating…”
ResultAssociation of TGF-β1 Genetic Variants with HPV16-positive Oropharyngeal Cancer
Guan, X., Sturgis, E. M., Lei, D., Liu, Z., Dahlstrom, K. R., Wei, Q., & Li, G. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2877 · Cited by 46
Evolution of Human Papillomavirus Carcinogenicity
Doorslaer, K. V., & Burk, R. D. (2010) · Advances in virus research · doi:10.1016/b978-0-12-385034-8.00002-8 · Cited by 57
“Figure adapted from Doorbar (2006).”
Potential Anti-HPV and Related Cancer Agents from Marine Resources: An Overview
Wang, S., Zhang, X., Guan, H., & Wang, W. (2014) · Marine Drugs · doi:10.3390/md12042019 · Cited by 45
“proteoglycans [19] and alpha 6 integrins [20].”
Baral, S. K., Biswas, P., Kaium, M. A., Islam, M. A., Dey, D., Saber, M. A., Rahaman, T. I., Arun Kumar, M., Emran, T. B., Hasan, M. N., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.883805 · Cited by 48
Widdice, L. E., & Moscicki, A. (2008) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2008.04.007 · Cited by 44
“E7 is also involved in the blockade of cellular apoptosis [2].”
BackgroundInfluentialKeegan, H., Inerney, J. M., Pilkington, L., Grønn, P., Silva, I., Karlsen, F., Bolger, N., Logan, C., Furuberg, L., O’Leary, J. J., et al. (2008) · Journal of Virological Methods · doi:10.1016/j.jviromet.2008.09.027 · Cited by 44
High Human Papillomavirus DNA loads in Inflammatory Middle Ear Diseases
Malagutti, N., Rotondo, J. C., Cerritelli, L., Melchiorri, C., Mattei, M. D., Selvatici, R., Oton, L., Stomeo, F., Mazzoli, M., Borin, M., et al. (2020) · Pathogens · doi:10.3390/pathogens9030224 · Cited by 45
Chen, S., Gao, C., Wu, Y., & Huang, Z. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00544 · Cited by 59
“Aberrant expression of oncoproteins encoded by HPV genetic material, such as E6 and E7, partially leads to epigenetic instability, which affects the carcinogenesis and metastasis of cervical cancer (Doorbar, 2006).”
BackgroundHuman papillomavirus: current status and issues of vaccination
Malik, H. I., Khan, F. H., & Ahsan, H. (2013) · Archives of Virology · doi:10.1007/s00705-013-1827-z · Cited by 51
“L1 is the major capsid protein, and L2 is the minor capsid protein [14].”
BackgroundMcIntosh, P. B., Martin, S. R., Jackson, D. J., Khan, J., Isaacson, E. R., Calder, L. J., Raj, K., Griffin, H. M., Wang, Q., Laskey, P., et al. (2008) · Journal of Virology · doi:10.1128/jvi.00509-08 · Cited by 58
“Although the E1∧E4 protein of HPV-1 is known to be N terminally cleaved during natural infection (2, 9), it is not yet clear whether HPV-16 E1∧E4 is similarly modified.”
BackgroundSelf-citationvan Baars, R., Griffin, H. M., Wu, Z., Soneji, Y., van de Sandt, M. M., Arora, R., van der Marel, J., ter Harmsel, B., Jach, R., Okoń, K., et al. (2015) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000498 · Cited by 43
Self-citationPapillomaviruses and Endocytic Trafficking
Siddiqa, A., Broniarczyk, J. K., & Banks, L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092619 · Cited by 45
“E7 reprograms the infected cell to enter S-phase by targeting, in part, the pRb family members, thus allowing the E2F family of transcription factors to activate the transcription of various cell cycle progression genes [1,127,128].”
BackgroundHublarová, P., Hrstka, R., Rotterová, P., Rotter, L., Coupkova, M., Badal, V., Nenutil, R., & Vojtěšek, B. (2009) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e31819d8a5c · Cited by 43
“Inactivation of p53 by degradation is thought to prevent growth arrest or apoptosis in response to E7-mediated cell cycle entry.(1) Infected keratinocytes can activate an antiviral defense that senses viral DNA as foreign and targets it for transcriptional repression.”
BackgroundHPV E6 proteins target Ubc9, the SUMO conjugating enzyme
Heaton, P. R., Deyrieux, A. F., Bian, X., & Wilson, V. G. (2011) · Virus Research · doi:10.1016/j.virusres.2011.04.001 · Cited by 43
“This association enhances p53 degradation through the ubiquitin-proteasomal route, resulting in loss of the p53-mediated cell cycle arrest and apoptotic functions (Doorbar, 2006).”
Hwang, L., Ma, Y., SHIBOSKI, S. C., Farhat, S., Jonte, J., & Moscicki, A. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis398 · Cited by 54
Yang, L., Yang, H., Wu, K., Shi, X., Ma, S., & Sun, Q. (2014) · Journal of Medical Virology · doi:10.1002/jmv.24043 · Cited by 42
“The HPV genome codes for only eight genes [Doorbar, 2006].”
BackgroundBuza, N., Cohen, P. J., Hui, P., & Parkash, V. (2010) · International Journal of Surgical Pathology · doi:10.1177/1066896909359914 · Cited by 42
Rauber, D., Mehlhorn, G., Fasching, P. A., Beckmann, M. W., & Ackermann, S. (2008) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2008.05.003 · Cited by 42
“Of all HPV proteins the highest frequency of humoral immune responses is noticed for the L1-capsid protein [16,17].”
BackgroundVerma, M., Erwin, S., Abedi, V., Hontecillas, R., Hoops, S., Leber, A. J., Bassaganya-Riera, J., & Ciupe, S. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0168133 · Cited by 44
Papillomaviruses in Domestic Cats
Munday, J. S., & Thomson, N. A. (2021) · Viruses · doi:10.3390/v13081664 · Cited by 42
“It appears that additional factors such as the speed of the immune response or the presence of other promotors of neoplasia are critical in determining whether or not a PV infection will result in cancer [8,20].”
BackgroundClinical, Histologic, and Immunohistochemical Analyses of Feline Squamous Cell Carcinoma In Situ
Favrot, C., Welle, M. M., Heimann, M., Godson, D. L., & Guscetti, F. (2008) · Veterinary Pathology · doi:10.1354/vp.46-1-25 · Cited by 42
Cruz, L., & Meyers, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068379 · Cited by 46
“Current papillomavirus vaccines target the major capsid protein L1 of the most common cancer-causing types, HPV16 and HPV18, which together account for 70% of cervical cancer cases, protecting against virus infection and development of neoplasias [12].”
BackgroundThe Changing Aetiology of Head and Neck Cancer: the Role of Human Papillomavirus
Evans, M., & Powell, N. G. (2010) · Clinical Oncology · doi:10.1016/j.clon.2010.05.024 · Cited by 40
Immunodiagnosis and Immunotherapeutics Based on Human Papillomavirus for HPV-Induced Cancers
Dong, Z., Hu, R., Du, Y. Z., Tan, L., Li, L., Du, J., Bai, L., Ma, Y., & Cui, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.586796 · Cited by 47
Detection and genotype analysis of human papillomavirus in non-small cell lung cancer patients
Sarchianaki, E., Derdas, S., Ntaoukakis, M., Vakonaki, E., Lagoudaki, E. D., Lasithiotaki, I., Sarchianaki, A., Koutsopoulos, A. V., Symvoulakis, E. K., Spandidos, D. A., et al. (2013) · Tumor Biology · doi:10.1007/s13277-013-1419-2 · Cited by 40
Davy, C. E., McIntosh, P. B., Jackson, D. J., Sorathia, R., Miell, M. D. D., Wang, Q., Khan, J., Soneji, Y., & Doorbar, J. (2009) · Virology · doi:10.1016/j.virol.2009.08.035 · Cited by 39
Self-citationMarkle, W., Conti, T., & Kad, M. (2013) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2013.05.001 · Cited by 52
Follow-up after treatment of cervical intraepithelial neoplasia by human papillomavirus genotyping
Wendel, S. B., Johansson, B., Borjesson, M., Arbyn, M., & Andersson, S. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.01.005 · Cited by 39
Hoffmann, C., Stanke, J., Kaufmann, A. M., Loddenkemper, C., Schneider, A., & Cichon, G. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181badc46 · Cited by 39
“7% of cervical cancers,(6) and HPV oncogenes are regularly expressed in high-grade CIN lesions.(6,7) The majority of earlier clinical trials to assess immunotherapy of cervical lesions focused on generating HPV E6/E7-specific CD8 T cells to eliminate HPV-infected cells.”
BackgroundOrlando, P. A., Gatenby, R. A., Giuliano, A. R., & Brown, J. S. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir717 · Cited by 39
“Distinct molecular differences separate LR and HR HPV types [4], and their course of infection in a host and their transmission between hosts varies.”
BackgroundSabol, I., Saláková, M., Šmahelová, J., Pawlita, M., Schmitt, M., Gašperov, N. M., Grce, M., & Tachezy, R. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.02328-07 · Cited by 45
“Because of their biological properties, HPVs cannot easily be grown in tissue culture, which makes the preparation of antigens for the routine detection of HPV difficult (10).”
BackgroundClere, N., Bermont, L., Fauconnet, S., Lascombe, I., Saunier, M., Vettoretti, L., Plissonnier, M., & Mougin, C. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.06.029 · Cited by 39
Virological characteristics of cervical cancers carrying pure episomal form of HPV16 genome
Cheung, J. L. K., Cheung, T., Yu, M. Y., & Chan, P. K. S. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.08.026 · Cited by 38
Olthof, N. C., Straetmans, J. M. J. A. A., Snoeck, R., Ramaekers, F. C. S., Kremer, B., & Speel, E. M. (2011) · Reviews in Medical Virology · doi:10.1002/rmv.714 · Cited by 43
Quint, K. D., de Koning, M. N. C., Quint, W. G. V., & Pirog, E. C. (2013) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2013.07.012 · Cited by 38
“Derangement of the cell cycle may become irreversible and lead to a fully transformed malignant phenotype [7].”
HPV16 infection of HaCaTs is dependent on β4 integrin, and α6 integrin processing
Aksoy, P., Abban, C. Y., Kiyashka, E., Qiang, W., & Meneses, P. I. (2013) · Virology · doi:10.1016/j.virol.2013.10.034 · Cited by 38
“To date, more than 150 human papillomavirus (HPV) types are identified by DNA sequencing and these types are commonly divided into five genera based on genotyping similarities (Doorbar, 2006; Doorbar et al., 2012).”
Merkley, M. A., Hildebrandt, E. F., Podolsky, R. H., Arnouk, H., Ferris, D. G., Dynan, W. S., & Stöppler, H. (2009) · Proteome Science · doi:10.1186/1477-5956-7-29 · Cited by 38
“Expression of the HPV E6 and E7 oncoproteins promotes neoplastic transformation by altering expression or interfering with the function of proteins involved in cell proliferation and apoptosis (reviewed in [9,10]).”
BackgroundBalcı, M., & Alkan, A. (2024) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2024.106491 · Cited by 39
Helfer, C. M., Yan, J., & You, J. (2014) · Viruses · doi:10.3390/v6083228 · Cited by 44
“The LCR contains the origin of replication and a transcriptional enhancer region containing multiple binding sites for the viral E2 protein and cellular transcription factors [6].”
BackgroundProteome scanning to predict PDZ domain interactions using support vector machines
Hui, S., & Bader, G. D. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-507 · Cited by 37
“Furthermore, studies have shown that the disruption of PDZ domain mediated interactions are associated with diseases such as human papillomavirus, cystic fibrosis and schizophrenia [3-5].”
BackgroundCervical cancer prevention and screening: the role of human papillomavirus testing
Aref‐Adib, M., & Freeman‐Wang, T. (2016) · The Obstetrician & Gynaecologist · doi:10.1111/tog.12279 · Cited by 43
Survey of Cervical Cancer Prediction Using Machine Learning: A Comparative Approach
Shetty, A., & Shah, V. (2018) · International Conference on Computing, Communication and Networking Technologies (ICCCNT) · doi:10.1109/icccnt.2018.8494169 · Cited by 37
“[4] As per research, nearly half of the cervical cancers detected in the United States are in women never screened in their lifetime, also women not tested themselves in the past half-decade account for an additional 10 percent of the cases.”
BackgroundThe different role of PD-L1 in head and neck squamous cell carcinomas: A meta-analysis
Tang, H., Zhou, X., Ye, Y., Zhou, Y., Wu, C., & Xu, Y. (2019) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.152768 · Cited by 38
HLA-Cw group 1 ligands for KIR increase susceptibility to invasive cervical cancer
Martin, M. P., Borecki, I. B., Zhang, Z., Nguyen, L., Ma, D., Gao, X., Qi, Y., Carrington, M. N., & Rader, J. S. (2010) · Immunogenetics · doi:10.1007/s00251-010-0477-5 · Cited by 40
“Although the lifetime risk of contracting human papillomavirus (HPV) is 80% in the general population, most HPV infections are successfully resolved by the host immune system ( Doorbar 2006 ).”
Warowicka, A., Kwaśniewska, A., & Gozdzicka-Jozefiak, A. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.01.001 · Cited by 40
“High-risk human papillomaviruses (HPVs 16/18) are the causative agent of cervical carcinogenesis [1].”
BackgroundHuman papillomavirus genotype-specific risks for cervical intraepithelial lesions
Nygård, M., Hansen, B. T., Kjaer, S. K., Hortlund, M., Tryggvadóttir, L., Munk, C., Lagheden, C., Sigurdardottir, L. G., Campbell, S., Liaw, K.-L., et al. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1814097 · Cited by 36
“This feature is well described for carcinogenic HPV types.(48) Interestingly, the non-carcinogenic HPV42 and HPV70 types were among the most prevalent types overall, and specifically in women older than 35 years.”
BackgroundMariani, L., Monfulleda, N., Alemany, L., Vizza, E., Marandino, F., Vocaturo, A., Benevolo, M., Quirós, B., Lloveras, B., Klaustermeier, J. E., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-259 · Cited by 36
“the cervical epithelium [7,8].”
Johansson, H., Bjelkenkrantz, K., Darlin, L., Dillner, J., & Forslund, O. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124460 · Cited by 37
“Continuous expression of HR-HPV E6 and E7 oncoproteins is necessary for transformation of normal cells to dysplastic cells [10].”
BackgroundTargeting mitotic chromosomes: a conserved mechanism to ensure viral genome persistence
Feeney, K. M., & Parish, J. L. (2009) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2008.1642 · Cited by 36
“In support of this, it has been shown that more than 99.7 per cent of cervical cancers contain highrisk HPV DNA with approximately 50 per cent of these containing HPV-16 DNA (Doorbar 2006).”
BackgroundMethodInfluentialHong, G., Zou, Z., Huang, Z., Deng, H., Chen, W., & Peng, H. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113044 · Cited by 36
Ashique, S., Hussain, A., Fatima, N., & Altamimi, M. A. (2023) · VirusDisease · doi:10.1007/s13337-023-00824-z · Cited by 41
“Over 200 distinct HPV strains have been found that infect epithelial cells [6], and about 40 of them show a preference for mucosal tissues.”
BackgroundCrosbie, E. J., & Kitchener, H. C. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.3.391 · Cited by 37
“Via their interaction with cellular tumour suppressor gene products, p53 and Rb, respectively, genetic alterations that promote invasiveness, metastasis and angiogenesis are facilitated and selected for [20].”
BackgroundA direct detection of human papillomavirus 16 genomic DNA using gold nanoprobes
Parmin, N. A., Hashim, U., Gopinath, S. C. B., & Nadzirah, S. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.10.060 · Cited by 35
“Cervical cancer infection was stimulated by high-risk types of Human Papillomavirus (HPV) strains 16, 18, 31 and 45 [6].”
BackgroundHammer, A., de Koning, M. N., Blaakær, J., Steiniche, T., Doorbar, J., Griffin, H. M., Mejlgaard, E., Svanholm, H., Quint, W. G. V., & Gravitt, P. E. (2019) · Papillomavirus Research · doi:10.1016/j.pvr.2019.02.004 · Cited by 35
Self-citationCancer Vaccines in Phase II/III Clinical Trials: State of the Art and Future Perspectives
Cecco, S., Muraro, E., Giacomin, E., Martorelli, D., Lazzarini, R., Baldo, P., & Dolcetti, R. (2010) · Current Cancer Drug Targets · doi:10.2174/156800911793743664 · Cited by 37
“FDA approved the vaccine known as Gardasil ® , which protects against infection by two types of oncogenic human papillomaviruses (HPV), types 16 and 18, which are responsible for approximately 70% of all cases of cervical cancer worldwide [10, 11].”
BackgroundSanchez, I. E., Dellarole, M., Gaston, K., & Gay, G. D. P. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm1104 · Cited by 40
Prevaccination genomic diversity of human papillomavirus genotype 6 (HPV 6)
Kocjan, B. J., Poljak, M., Cimerman, M., Gale, N., Potočnik, M., Bogovac, Ž., & Seme, K. (2009) · Virology · doi:10.1016/j.virol.2009.06.030 · Cited by 34
“Many important functions have been attributed to the high-risk HPV E6/E7 proteins, including binding and degradation of p53, interacting with retinoblastoma (Rb) proteins, facilitating the proliferation of infected epithelial cells and, consequently, inducing cellular transformation (Doorbar, 2006).”
BackgroundHuman papilloma virus (HPV) molecular diagnostics
Κroupis, C., & Vourlidis, N. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.685 · Cited by 34
Lechner, M., & Fenton, T. R. (2016) · Advances in genetics · doi:10.1016/bs.adgen.2015.12.001 · Cited by 36
Molecular Patho-mechanisms of cervical cancer (MMP1)
Kurnia, I., Rauf, S., Hatta, M., Arifuddin, S., Hidayat, Y. M., Natzir, R., Kaelan, C., Bukhari, A., Pelupessy, N. U., & Patelonggi, I. J. (2022) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2022.103415 · Cited by 39
Viral Interplay with the Host Sumoylation System
Wilson, V. G. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-50044-7_21 · Cited by 37
“HPV E7 stimulates the cell cycle by promoting E2F release from pRb, while E6 promotes p53 degradation in an ubiquitindependent and independent manner (Doorbar 2006).”
BackgroundHuman Papillomavirus Types in Invasive Cervical Cancer Specimens From Turkey
Usubutün, A., Alemany, L., Küçükali, T., Ayhan, A., Yuce, K., de Sanjosé, S., Font, R., Lloveras, B., Klaustermeier, J. E., Quint, W. G. V., et al. (2009) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e3181aaba0d · Cited by 34
“Today, over 100 different HPV types have been identified (16), and more than 30 of these are known to infect the cervical epithelium (17).”
BackgroundRashwan, H., Lubis, S. H., & Ni, K. A. (2011) · PubMed · Cited by 34
Matamoros, J. A., da Silva, M. I. F., de Moura, P. M. M. F., Leitão, M. D. C. G., & Coimbra, E. C. (2019) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2019.20.9.2715 · Cited by 39
“Human papillomavirus (HPV) is the main cause of cervical cancer (zur Hausen, 2001) and it has been shown that infection and cancer progression depend on the type of HPV and the ability of the host immune system to control viral infection (Doorbar, 2006).”
BackgroundPortari, E. A., Russomano, F. B., de Camargo, M. J., Gayer, C. R. M., Guillobel, H., Santos-Rebouças, C. B., & Macedo, J. M. B. (2013) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31826f5cf6 · Cited by 33
“In addition, persistent infection by high-risk human papillomavirus (HR-HPV) is strongly associated with premalignant lesions and invasive squamous cell carcinoma (4).”
BackgroundInfluentialZeier, M., Botha, M. H., Engelbrecht, S., Machekano, R. N., Jacobs, G. B., Isaacs, S., Schalkwyk, M. V., der Merwe, F. H. V., Mason, D., & Nachega, J. B. (2014) · AIDS · doi:10.1097/qad.0000000000000512 · Cited by 33
“It is thought to be due to the increased incidence and persistence of cervical human papilloma virus (HPV) infection in HIV-positive women, the recurrence thereof after excision treatment [5–14], and possible reactivation of latent HPV infection [5, 14–16].”
BackgroundSchütze, D. M., Snijders, P. J. F., Bosch, L., Kramer, D., Meijer, C. J. L. M., & Steenbergen, R. D. M. (2013) · Journal of Virology · doi:10.1128/jvi.02859-13 · Cited by 34
“High-grade CIN lesions (CIN2/3) mainly represent transforming infections and are characterized by deregulated expression of the early viral E6 and E7 genes in the proliferating basal cells of the epithelium (3, 4).”
BackgroundLehoux, M., Gagnon, D., & Archambault, J. (2014) · Journal of Virology · doi:10.1128/jvi.00379-14 · Cited by 33
Zhou, X., Han, S., Wang, S., Chen, X., Dong, J., Shi, X., Xia, Y., Wang, X., Hu, Z., & Shen, H. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.05.011 · Cited by 33
“, HPV-6 and -11) types [2,6,7] according to their risks causing cervical cancer.”
BackgroundKhan, J., Davy, C. E., McIntosh, P. B., Jackson, D. J., Hinz, S., Wang, Q., & Doorbar, J. (2011) · Journal of Virology · doi:10.1128/jvi.02158-10 · Cited by 33
Self-citationHuman papillomavirus (HPV) screening and cervical cancer burden. A Brazilian perspective
Lorenzi, A. T., Syrjänen, K. J., & Longatto‐Filho, A. (2015) · Virology Journal · doi:10.1186/s12985-015-0342-0 · Cited by 38
“HPVinduced cell transformation is mediated by the viral E6 and E7 oncoproteins interfering with the cell cycle regulators of the host cells, starting at the basal cells layer and gradually extending to the full epithelial thickness [9, 18].”
BackgroundMouse papillomavirus infections spread to cutaneous sites with progression to malignancy
Cladel, N. M., Budgeon, L. R., Cooper, T. K., Balogh, K. K., Christensen, N. D., Myers, R. L., Majerčiak, V., Gotte, D., Zheng, Z., & Hu, J. (2017) · Journal of General Virology · doi:10.1099/jgv.0.000926 · Cited by 33
Intrabody strategies for the treatment of human papillomavirus-associated disease
Doorbar, J., & Griffin, H. M. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.5.677 · Cited by 33
“In most cases, the development of cervical cancer is associated with the integration of high-risk viral sequences into the host cell chromosome, which leads to overexpression of the viral oncogenes E6 and E7, and loss of the viral regulatory proteins E1 and E2 [18].”
BackgroundSelf-citationHuman papillomavirus status, anal cytology and histopathological outcome in HIV ‐positive patients
Dietrich, A., Hermans, C., Heppt, M. V., Ruzicka, T., Schauber, J., & Reinholz, M. (2015) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13205 · Cited by 32
Recent Updates on Viral Oncogenesis: Available Preventive and Therapeutic Entities
Chowdhary, S., Deka, R., Panda, K., Kumar, R., Solomon, A. D., Das, J., Kanoujiya, S. N., Gupta, A. K., Sinha, S., Ruokolainen, J., et al. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c01080 · Cited by 33
de Oliveira, C. M., Bravo, I. G., Souza, N. C. S., Genta, M. L. N. D., Fregnani, J. H. T. G., Tacla, M., Carvalho, J. P., Longatto‐Filho, A., & Levi, J. E. (2015) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2015.07.002 · Cited by 32
Integrated virus-host methylome analysis in head and neck squamous cell carcinoma
Wilson, G. A., Lechner, M., Köferle, A., Carén, H., Butcher, L. M., Feber, A., Fenton, T. R., Jay, A., Boshoff, C., & Beck, S. (2013) · Epigenetics · doi:10.4161/epi.25614 · Cited by 32
Bryant, D. J., Tristram, A. J., Liloglou, T., Hibbitts, S. J., Fiander, A., & Powell, N. G. (2013) · Journal of Clinical Virology · doi:10.1016/j.jcv.2013.10.029 · Cited by 32
“L1 and L2 are structural proteins, expressed in the upper layers of HPV infected epithelia, and expression is usually lost in transforming infections, whilst expression of E6 and E7 is maintained [29].”
BackgroundChan, P. K. S., Cheung, J. L. K., Cheung, T., Lo, K. W. K., Yim, S. F., Siu, S. S. N., & Tang, J. W.-T. (2007) · The Journal of Infectious Diseases · doi:10.1086/520884 · Cited by 32
“Because the episomal form of HPV genome is present during the vegetative replicating phase of the viral life cycle [4], it is to be expected that viral load would be higher in samples having the pure episomal genome than in those having either the pure integrated form or the concomitant form.”
BackgroundMeta-Analysis of Downregulated E-Cadherin as a Poor Prognostic Biomarker for Cervical Cancer
Peng, J., Qi, S., Wang, P., Li, W., Song, L., Liu, C., & Li, F. (2015) · Future Oncology · doi:10.2217/fon.15.332 · Cited by 31
Filho, S. M. A., Chaves, C. B. P., Felix, S. P., Basto, D. L., de Almeida, L. M., & Moreira, M. Â. M. (2018) · Papillomavirus Research · doi:10.1016/j.pvr.2018.04.002 · Cited by 31
“The mechanisms of carcinogenesis induced by HR-HPV involve inhibition of p53 and pRB cell proteins by E6 and E7 oncoproteins, respectively [1,7,8], consequently to which, a severe chromosome instability is generated, favoring HPV DNA disruption and integration into the host genome.”
BackgroundImmunometabolic Alterations by HPV Infection: New Dimensions to Head and Neck Cancer Disparity
Chaudhary, S., Ganguly, K., Muniyan, S., Pothuraju, R., Sayed, Z., Jones, D. T., Batra, S. K., & Macha, M. A. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy207 · Cited by 31
“Thus, HPV DNA along with high levels of p16INK4a is considered a robust prognostic marker.”
BackgroundInfluentialOu, R., Lv, M., Liu, X., Lv, J., Zhao, J., Zhao, Y., Li, X., Li, W., Zhao, L., Lǐ, J., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202000762r · Cited by 36
Aldakak, L., Huber, V. M., Rühli, F. J., & Bender, N. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.02.022 · Cited by 31
Metadata
- Authors
- Doorbar, J.
- Affiliations
- National Institute for Medical Research (GB)
- Corresponding author
- Doorbar, John
- ORCID
- Doorbar, John
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2006-04-11
- Volume
- 110
- Issue
- 5
- Pages
- 525-541
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W2052489835
- Cited by
- 1,072
- References
- 179
- Citations by year
- 2026: 30 · 2025: 35 · 2024: 34 · 2023: 41 · 2022: 51 · 2021: 43 · 2020: 52 · 2019: 45 · 2018: 60 · 2017: 55 · 2016: 58 · 2015: 64 · 2014: 73 · 2013: 98 · 2012: 83
- FWCI
- 5.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Keywords
- human papillomavirus, cervical cancer, HPV16, high-risk HPV, viral gene expression, cervical neoplasia, cervical transformation zone, E6 oncoprotein, E7 oncoprotein, retinoblastoma protein, p53 degradation, PDZ domain proteins, abortive infection, viral latency, immune clearance
- MeSH terms
- Uterine Cervical Neoplasms, Female, Humans, Precancerous Conditions, Virus Latency, Disease Progression, Papillomaviridae, Papillomavirus Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.